In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elsevier acquires Windhover

This article was originally published in The Gray Sheet

Executive Summary

FDC Reports' parent company Elsevier builds upon its news and business intelligence services for the medical device and drug industries with the acquisition of Windhover Information, announced March 10. Windhover's businesses include the Strategic Transactions Database, a number of device and drug partnering and strategy conferences, and the journals IN VIVO and RPM Report. Windhover will operate within Elsevier's Pharma Business Intelligence Unit, which includes FDC Reports, publisher of "The Gray Sheet" and "The Pink Sheet," and the Inteleos drug development database
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT025883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel